Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Choosing the right retirement plan is vital for meeting your financial goals. Explore various plans to find the best fit for you.
25,593 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Memory stocks surge as SK Hynix announces a capacity expansion, lifting SanDisk and Western Digital and signaling ren...
A choppy week toppled many growth names, but poet technologies stock sliding captured particular attention. Here’s wh...
Take a pause this weekend to dive into long-form investing stories. From the science behind durable moats to how ever...
UBS analysts view Target's planned $2 billion investment for 2026 as a bold, two-pronged turnaround bet. The plan spl...
President Trump touts a plan for a government-backed insurance agency to cover Gulf shipping against political risk. ...
Cardano faces a pivotal test as founder Charles Hoskinson lays out a four-layer rescue plan blending governance refor...
Dolly Parton sets Broadway marks a bold return after health setbacks, blending big dreams with big budgets. This arti...
SEC Chair Atkins rejects calls for immediate market intervention, outlining a rulemaking roadmap for crypto assets an...
Salesforce just delivered a solid quarter with revenue and adjusted earnings topping expectations and a $50 billion b...
The International Energy Agency announced a historic emergency stock release of 400 million barrels, aiming to cool e...
Lucid Group faces a bumpy road as the EV market evolves. This report outlines 2026-2030 price paths for lucid group (...